In circumstances of high risk, or when volume resuscitation is required, the hazard of developing progressive anemia, end-organ ischemia, or fluid overload should be considered, and adherence to restrictive or Hb-based transfusion strategies is not only suboptimal but outside the premise of the guideline. This evidence concerns the gene GSTM1 and anemia.